Drugs Q1 Unclaimed

Adis International Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

NA

Drugs focuses its scope in these topics and keywords: patients, therapeutic, review, disordersrizatriptandarunavirbeclometasone, dipropionateformoterollisinopriloptimal, differences, developmentvonoprazan, development, current, concepts, ...

Type: Journal

Type of Copyright: NA

Languages: English

Open Access Policy: NA

Type of publications: NA

Publication frecuency: NA

Price

2990 €

Gold OA

-

Green OA

NA €

Non OA

Metrics

Drugs

1,589

SJR Impact factor

164

H Index

171

Total Docs (Last Year)

504

Total Docs (3 years)

9864

Total Refs

3813

Total Cites (3 years)

484

Citable Docs (3 years)

7,60

Cites/Doc (2 years)

57,68

Ref/Doc

Aims and Scope


patients, therapeutic, review, disordersrizatriptandarunavirbeclometasone, dipropionateformoterollisinopriloptimal, differences, developmentvonoprazan, development, current, concepts, doxorubicinsumatriptan, effects, emerging, eosinophilic, epilepsypolyethylenglykolumhülltes, established, fibrillation, global, granulomatosis, complications, combined, cellular, ampakainate, anticoagulants, antifungal, approval, atrial, azelastinedrugs, biofilmbased, blockade, btargeting, butylbromidenovel, cancer, cannabidiol, carcinoma, cell, NA


Best articles

Abiraterone Acetate: A Review in Metastatic Castration-Resistant Prostrate Cancer

View more

Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer

View more

Acotiamide: First Global Approval

View more

Acute Otitis Media in Sweden

View more

Adefovir Dipivoxil

View more

Advanced Glycation Endproduct Crosslinking in the Cardiovascular System

View more

Anthelmintics

View more

Antifungal Resistance Trends Towards the Year 2000

View more

Are All Dopamine Agonists Essentially the Same?

View more

Argatroban

View more

As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?

View more

Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia

View more
SHOW MORE ARTICLES

Bacteria-Triggered Reactive Arthritis

View more

Basiliximab

View more

Benefit:Risk Profile of Budesonide in Obstructive Airways Disease

View more

Betrixaban for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients: Putting the APEX Results into Practice

View more

Carvedilol

View more

Caspofungin

View more

Cefepime

View more

Cefodizime

View more

Choosing the Right beta-Blocker

View more

Cidofovir

View more

Clinical Aspects of Invasive Candidiasis in Paediatric Patients

View more

Clinical Pharmacokinetics of Felodipine

View more

Comments

No comments ... Be the first to comment!